We estimate that the CEO and Director of Taysha Gene Therapies, Inc. ($TSHA), Sean Nolan, received a compensation of $4,099,065 in 2025. This is a decrease of -15.34% from an estimated $4,727,861 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 22, 2026. Note that parsing errors may occur.
You can track $TSHA on Quiver Quantitative's $TSHA stock dashboard.
$TSHA Stock Insider Trading Activity
$TSHA Stock insiders have traded $TSHA stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $TSHA stock by insiders over the last 6 months:
- SUKUMAR NAGENDRAN (President and Head of R&D) has made 0 purchases and 6 sales selling 886,222 shares for an estimated $4,077,374.
- SEAN P. NOLAN (Chief Executive Officer) has made 0 purchases and 2 sales selling 178,101 shares for an estimated $840,196.
- KAMRAN ALAM (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 104,472 shares for an estimated $492,522.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TSHA Stock Hedge Fund Activity
We have seen 117 institutional investors add shares of $TSHA Stock stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RTW INVESTMENTS, LP removed 8,623,287 shares (-34.5%) from their portfolio in Q4 2025, for an estimated $47,428,078
- VESTAL POINT CAPITAL, LP added 8,250,000 shares (+150.0%) to their portfolio in Q4 2025, for an estimated $45,375,000
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 3,722,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $20,471,000
- STATE STREET CORP added 3,553,619 shares (+49.1%) to their portfolio in Q4 2025, for an estimated $19,544,904
- POINT72 ASSET MANAGEMENT, L.P. removed 3,462,788 shares (-47.2%) from their portfolio in Q4 2025, for an estimated $19,045,334
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 2,663,835 shares (-49.5%) from their portfolio in Q4 2025, for an estimated $14,651,092
- POLAR CAPITAL HOLDINGS PLC added 2,637,524 shares (+49.8%) to their portfolio in Q4 2025, for an estimated $14,506,382
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TSHA Stock Analyst Ratings
Wall Street analysts have issued reports on $TSHA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 01/06/2026
- Citizens issued a "Market Outperform" rating on 11/05/2025
To track analyst ratings and price targets for $TSHA Stock, check out Quiver Quantitative's $TSHA forecast page.
$TSHA Stock Price Targets
Multiple analysts have issued price targets for $TSHA recently. We have seen 5 analysts offer price targets for $TSHA in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Whitney Ijem from Canaccord Genuity set a target price of $17.0 on 04/06/2026
- Geulah Livshits from Chardan Capital set a target price of $12.0 on 03/19/2026
- Gil Blum from Needham set a target price of $12.0 on 03/19/2026
- Yanan Zhu from Wells Fargo set a target price of $11.0 on 01/05/2026
- Silvan Tuerkcan from Citizens set a target price of $8.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
